Visual Universitätsmedizin Mainz

News

2020

  • 17.10.2020: Recent publication in "Cancer Gene Therapy"! A new study from CBU identified a critical role for the understudied , atypical MAPK ERK3 in controlling KRAS-mediated Non small cell lung carcinomas. KRAS is one of the most frequently mutated oncogenes and mechanisms driving tumourigenesis mediated by this oncogene have been intensively studied. Our new work demonstrated that the kinase activity of ERK3 is required for KRAS-mediated NSCLCs thus prompting development of ERK3 specific inhibitors. To read the full story click here

2019

  • 05.04.19: We are Leica Reference Center. For the German press release please click here

2018

2016

2015

2014